The critical step in porphyrin biosynthesis is the condensation of two molecules of amino-levulinic acid (ALA) into the monopyrrole, porphobilinogen. This reaction is catalyzed by porphorbilinogen synthase (PBGS). All PBGS contain at least 8 metal ions; the mammalian enzyme is a Zn(4)Zn(4) species, with two Zn(2+) per dimeric unit in a homooctameric structure. In each homodimer, one Zn is bound to what is known as the """"""""A"""""""" site, one Zn(2+) is bound at the """"""""B"""""""" site. This proposal has four specific aims focussed on determination of the structure and catalytic mechanism of this essential enzyme.
The first aim i s to determine the chemical structure of the PBGS-catalyzed reaction intermediates. Three approaches will be used. First, site-directed mutagenesis will be used to make substitutions at residues thought to play a role as a covalent catalyst, a metal ligand, or Bronsted base/acid. Second, fluorinated substrate(s) will be used that cannot undergo turnover. Third, rapid quench approaches will be tried.
The second aim i s to determine the manner by which PBGS from various species use metal ions. This will involve the preparation of a number of PBGSs from various sources, with various combinations of Zn(2+), Mg(2+), Mn(2+), followed by analysis of metal ligation by EXAFS and ESR, and function. The inhibition of these several forms of PBGS by Pb(2+) is the focus of the third aim which is to determine whether the mechanism of lead inhibition is common to all of these enzyme forms. The last aim is to complete the x-ray structural determination of PBGS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003654-14
Application #
2430302
Study Section
Metallobiochemistry Study Section (BMT)
Project Start
1991-04-01
Project End
1999-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
14
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
872612445
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Jaffe, Eileen K (2016) The Remarkable Character of Porphobilinogen Synthase. Acc Chem Res 49:2509-2517
Ramirez, Ursula D; Nikonova, Anna S; Liu, Hanqing et al. (2015) Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization. BMC Cancer 15:436
Lentz, Christian S; Halls, Victoria S; Hannam, Jeffrey S et al. (2014) wALADin benzimidazoles differentially modulate the function of porphobilinogen synthase orthologs. J Med Chem 57:2498-510
Lawrence, Sarah H; Selwood, Trevor; Jaffe, Eileen K (2013) Environmental contaminants perturb fragile protein assemblies and inhibit normal protein function. Curr Chem Biol 7:196-206
Jaffe, Eileen K (2013) Impact of quaternary structure dynamics on allosteric drug discovery. Curr Top Med Chem 13:55-63
Jaffe, Eileen K; Lawrence, Sarah H (2012) Allostery and the dynamic oligomerization of porphobilinogen synthase. Arch Biochem Biophys 519:144-53
Selwood, Trevor; Jaffe, Eileen K (2012) Dynamic dissociating homo-oligomers and the control of protein function. Arch Biochem Biophys 519:131-43
Jaffe, Eileen K; Lawrence, Sarah H (2012) The morpheein model of allostery: evaluating proteins as potential morpheeins. Methods Mol Biol 796:217-31
Jaffe, Eileen K; Shanmugam, Dhanasekaran; Gardberg, Anna et al. (2011) Crystal structure of Toxoplasma gondii porphobilinogen synthase: insights on octameric structure and porphobilinogen formation. J Biol Chem 286:15298-307
Lawrence, Sarah H; Selwood, Trevor; Jaffe, Eileen K (2011) Diverse clinical compounds alter the quaternary structure and inhibit the activity of an essential enzyme. ChemMedChem 6:1067-73

Showing the most recent 10 out of 49 publications